AU536522B2 - Cancer diagnosis method - Google Patents

Cancer diagnosis method

Info

Publication number
AU536522B2
AU536522B2 AU57193/80A AU5719380A AU536522B2 AU 536522 B2 AU536522 B2 AU 536522B2 AU 57193/80 A AU57193/80 A AU 57193/80A AU 5719380 A AU5719380 A AU 5719380A AU 536522 B2 AU536522 B2 AU 536522B2
Authority
AU
Australia
Prior art keywords
diagnosis method
cancer diagnosis
cancer
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57193/80A
Other languages
English (en)
Other versions
AU5719380A (en
Inventor
Stanley T. Crooke
Louis Galvan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU5719380A publication Critical patent/AU5719380A/en
Application granted granted Critical
Publication of AU536522B2 publication Critical patent/AU536522B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU57193/80A 1979-04-10 1980-04-03 Cancer diagnosis method Ceased AU536522B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10
US028732 1979-04-10

Publications (2)

Publication Number Publication Date
AU5719380A AU5719380A (en) 1980-10-16
AU536522B2 true AU536522B2 (en) 1984-05-10

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57193/80A Ceased AU536522B2 (en) 1979-04-10 1980-04-03 Cancer diagnosis method

Country Status (24)

Country Link
JP (1) JPS55143441A (fi)
KR (1) KR830002502A (fi)
AR (1) AR222700A1 (fi)
AT (1) AT365343B (fi)
AU (1) AU536522B2 (fi)
BE (1) BE882669A (fi)
CH (1) CH644453A5 (fi)
DE (1) DE3013837A1 (fi)
DK (1) DK149980A (fi)
ES (1) ES490396A0 (fi)
FI (1) FI801078A (fi)
FR (1) FR2454099A1 (fi)
GB (1) GB2047712B (fi)
GR (1) GR67692B (fi)
HU (1) HU183122B (fi)
IE (1) IE49981B1 (fi)
IL (1) IL59772A (fi)
IT (1) IT1143135B (fi)
LU (1) LU82345A1 (fi)
NL (1) NL8002094A (fi)
NO (1) NO801018L (fi)
PH (1) PH15637A (fi)
SE (1) SE8002602L (fi)
ZA (1) ZA802141B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
IT1143135B (it) 1986-10-22
IL59772A0 (en) 1980-06-30
DK149980A (da) 1980-10-11
KR830002502A (ko) 1983-05-30
IE49981B1 (en) 1986-01-22
BE882669A (fr) 1980-10-06
ES8103380A1 (es) 1981-02-16
FR2454099A1 (fr) 1980-11-07
CH644453A5 (fr) 1984-07-31
NO801018L (no) 1980-10-13
NL8002094A (nl) 1980-10-14
FI801078A (fi) 1980-10-11
IT8048370A0 (it) 1980-04-09
IL59772A (en) 1983-05-15
AR222700A1 (es) 1981-06-15
FR2454099B1 (fi) 1984-01-27
AT365343B (de) 1982-01-11
GR67692B (fi) 1981-09-07
PH15637A (en) 1983-03-11
AU5719380A (en) 1980-10-16
GB2047712A (en) 1980-12-03
ATA195780A (de) 1981-05-15
HU183122B (en) 1984-04-28
DE3013837A1 (de) 1980-10-30
LU82345A1 (fr) 1980-12-16
IE800693L (en) 1980-10-10
GB2047712B (en) 1983-02-23
SE8002602L (sv) 1980-12-09
ZA802141B (en) 1981-04-29
JPS55143441A (en) 1980-11-08
ES490396A0 (es) 1981-02-16

Similar Documents

Publication Publication Date Title
AU534769B2 (en) Method
AU533096B2 (en) Method
AU529947B2 (en) Method
AU531547B2 (en) Method
AU539791B2 (en) Method
AU543159B2 (en) Method
AU531350B2 (en) Method
AU6194080A (en) Method
AU6166380A (en) Method
AU6191780A (en) Method
AU5900980A (en) Method
AU5520380A (en) Method
AU6165480A (en) Method
AU539149B2 (en) Method
AU539025B2 (en) Method
AU529582B2 (en) Method
AU6171480A (en) Method
AU534665B2 (en) Method
AU546195B2 (en) Method
AU535826B2 (en) Method
AU6191880A (en) Method
AU6209180A (en) Method
AU531484B2 (en) Method
AU525275B2 (en) Method
AU538216B2 (en) Method